FDA warns about clarithromycin being linked to increases in deaths long ( up to 10 yrs) after its use in patients with heart disease. The mechanism of this adverse effect is unclear. Providers are therefore advised, following this discovery, to carefully evaluate and substitute with regularly available alternatives.
READ MORE